Twice-Yearly Lenacapavir for HIV Prevention in Cisgender Gay Men, Transgender, and Gender-Diverse People: Interim Analysis Result from the PURPOSE 2 study

Conference Reports for NATAP

HIVR4P 2024
5th HIV Research for
Prevention Conference
Lima, Peru - Oct 6-10 2024


Twice-Yearly Lenacapavir for HIV Prevention in Cisgender Gay Men, Transgender, and Gender-Diverse People: Interim Analysis Result from the PURPOSE 2 study

	Colleen Kelley 5th HIVR4P Lima Peru Oct 6-10